Medical Education

Uni

University of Freiburg

Product: Ethics in Medicine
Title: 1. Freiburg Symposium on fundamental questions of humanity in medicine
Medium: Symposium
Objective: Increase the visibility of the Institute for Ethics and History of Medicine

Yondelis

PharmaMar

Product: Yondelis®
Title: Gynacologic Tumors
Medium: Symposium on the occasion of the DKK 2010
Objective:Interactive design through TED query, establishment of PharmaMar as a pioneer in the Gynecological Oncology field

Mabthera

Roche

Product: MabThera®
Title: MabThera® CLL
Medium: Sales Kick-Off for extended market authorization of MabThera®
Objective: Training of sales representatives and communication of specifics of CLL

pradaxa

Boehringer Ingelheim

Product: Pradaxa®
Title: Thromboembolic Academy (TEA)
Medium: Approximately 120 regional, certified continuing education events in 2008/2009
Objective: Enhance the visibility of the first oral direct Thrombin inhibitor and the importance of Thromboembolism Prophylaxis

wilsede

Wilsede-Akademie (Academy)

Product: Oncology
Title: Wilsede-Akademie (Academy)
Medium: Annual Meetings
Objective: Establishment of a joint North-East German continuing education platform
Website Wilsede-Akademie

paion

Paion / Lundbeck

Product: Desmoteplase
Title: How can the time-window of thrombolysis in stroke be safely extended?
Medium: ESC Symposium 2006, Brussels
Objective: Establishment of Paion & Lundbeck as pioneers in stroke therapy and communication of the latest study results of Desmoteplase

mundica

Mundipharma Cambridge (International)

Product: Depocyte®
Title: Challenges in the diagnosis, therapy and prevention of metastases in liquor
Medium: Meet the Expert Evening: A Symposium on the occasion of the IMCL 2005, Lugano
Objective: Information and discussion about recent developments with European experts .

glsg

Roche

Product: MabThera®
Title: Evolution of standards of care in follicular NHL
Medium: 1 Day – CME event on the occasion of the GLSG Study Meeting (6 CME points)
Objective: Current results of NHL therapy and outlook for future therapies

carpe diem

Roche

Product: Xeloda®
Title: Carpe Diem – What happens next?
Medium: Patients – Journal for women with breast cancer
Objective: Education and motivation of patients in the form of continuous publication of modern journals.

xeloda

Roche / Sanofi-Aventis

Product: Xeloda® / Eloxatin®
Title: CRC Symposium – Colorectal Carcinoma
Medium: Interactive 1 Day – CME continuuing education events under the patronage of the AIO (10 CME points)
Objective: Overview of state-of-the-art CRC therapy(treatment) and discussion about future therapeutic strategies

mabthera

Roche

Product: MabThera®
Title: Expert Workshop NHL & CLL
Medium: Opinion leader work
Objective: Successful continuation of the – with experts highly regarded – concept: „State-Of-The-Art“ - discussions and projections

copaxone

Teva Pharma / Sanofi-Aventis

Product: Copaxone®
Title: Copaxone® – Trust by Continuity
Medium: CD-ROM with EDSS Software / Direct marketing campaign and an interactive workshop
Objective: Easier diagnosis / Training for better and more effective therapy.

xeloda

Roche

Product: Xeloda®
Title: Interdisciplinary Expert Workshop on „Colorectal Cancer“
Medium: Program, Publication of results in the journal „Der Onkologe“ (The Oncologist)
Objective: Current treatment of colorectal cancers and discussion on future issues